Virgin Voyages eliminates pre-embarkation Covid-19 testing for cruises

Virgin Voyages has responded immediately to the decision by the US CDC to end its voluntary Covid-19 programme for cruise ships by stating that it would be removing pre-embarkation testing for sailings from July 24th onwards for EU sailings and from July 27th for on US sailings.

However, vaccination requirements will remain in place for both the Scarlet Lady (IMO 9804801), operating out of the US, and the Valiant Lady (IMO 9805336) in the EU.

From the dates mentioned above, passengers will no longer be required to complete a pre-embarkation Covid test, applicable across the fleet, including US and EU operations. For US sailings, passenger vaccination requirements will now be marked at 90%. This opens the opportunity for passengers who are not vaccinated to contact Virgin Voyages’ Sailor Services to book a sailing if these thresholds are met. Ship crew on all US and EU sailings will still have to be fully vaccinated.

2020-built, Bahamas-flagged, 108,192 gt Scarlet Lady is owned by VC Ship One Ltd care of V Cruises US LLCof Plantation, Florida, USA. It is managed by Virgin Voyages of Plantation, Florida, and ISM manager is Virgin Cruises Intermediate of Plantation, Florida. It is entered with Skuld (Business Unit Skuld Oslo 1) on behalf of Virgin Cruises Intermediate Ltd.

2021-built, Bahamas-flagged, 108,192 gt Valiant Lady is owned by VC Ship Two Ltd care of V Cruises US LLC of Plantation, Florida, USA, and has the same management structure and liability insurance as Scarlet Lady